National Wealth Fund, Barclays and Emirates NBD Provide £368.5M Debt for CWG and Kadans Science Partner's One North Quay

•4 min read
A rendering of One North Quay in Canary Wharf, shown within the London skyline, illustrating the life sciences and innovation development supported by the £368.5 million financing package from the National Wealth Fund, Barclays and Emirates NBD.
A rendering of One North Quay in Canary Wharf, shown within the London skyline, illustrating the life sciences and innovation development supported by the £368.5 million financing package from the National Wealth Fund, Barclays and Emirates NBD.| Photo: Kadans

The National Wealth Fund, Barclays and Emirates NBD have provided a £368.5 million debt financing package for One North Quay, a life sciences and innovation development in Canary Wharf, London, being delivered by CWG and Kadans Science Partner. The financing was announced Nov. 16, 2026.

The National Wealth Fund is committing £147 million of the total, alongside Barclays and Emirates NBD. It is the National Wealth Fund's first deal in the life sciences sector. The financing will fund the continued development and fit-out of the project, which is due to be completed in early 2028.

One North Quay Financing Details

The commitment was announced in a speech by Secretary of State for Business, Innovation, Science and Trade Jonathan Reynolds to mark London Life Sciences Week. The £368.5 million package is development financing, and no sale price or capitalization rate was announced. Based on the 570,000-square-foot specification in the financing announcement, the debt equates to roughly £646 per square foot. That figure compares financing to area and is not a property valuation or loan-to-value measure.

The £368.5 million debt package should not be read as the total project cost.

Project Scope and Construction Status

One North Quay is described as one of the largest and most technically sophisticated purpose-built commercial science, technology and innovation buildings of its kind in Europe. CWG and Kadans Science Partner are developing the building, which will provide around 570,000 square feet of flexible workspace and laboratory space. It will offer specialist facilities for established companies and growing small and medium-sized enterprises, supporting Canary Wharf's ecosystem of life science, technology and innovation organizations.

The project recently held its topping-out ceremony, with construction reaching its full 23-storey height. The development is also described as the first phase of the broader North Quay scheme. The project is expected to support an estimated 440 annual full-time-equivalent jobs during the peak year of construction.

Public materials cite two area figures for the building. The financing and topping-out announcements use approximately 570,000 square feet, while CWG investor materials and a related Kadans leasing announcement refer to an approximately 823,000-square-foot gross internal area. The difference may reflect different measurement bases.

Lender and Developer Comments

Steijn Ribbens, CEO of Kadans Science Partner, said: "We are delighted to reach this key project milestone of securing the financing for One North Quay. The milestone shows the significant strength of the London science & innovation ecosystem and its future growth potential. One North Quay provides some of the most unique science & innovation infrastructure in the UK helping to grow organisations from quantum computing to biotechnology. We look forward to working with our partner CWG and the National Wealth Fund, Barclays and Emirates NBD to bring the building to life."

Oliver Holbourn, CEO of the National Wealth Fund, said: "The UK is home to world-leading science and innovation, and businesses need the right infrastructure if they are to translate that innovation into economic growth. The National Wealth Fund's financing for One North Quay, our first deal in the life sciences sector, will help provide the high-quality, specialist space businesses need to start, grow and scale here in the UK."

Shobi Khan, CEO of CWG, said: "This financing is testament to Canary Wharf's position as a home for science, technology, innovation and AI. Together with Kadans Science Partner, we are delivering a building designed to meet the needs of high-growth companies with direct access to an established innovation community of more than 180 start-ups and scale-ups located alongside global corporates, investors and world-class transport links. The combination of our high-quality specification and our established ecosystem will support businesses start, scale and grow here."

Jason Constable, Head of Real Estate at Barclays UK Corporate Bank, said: "The UK has a world-class life sciences sector, and ensuring ambitious businesses have the infrastructure they need to grow is critical to maintaining that position. Barclays is proud to support One North Quay alongside the National Wealth Fund and Emirates NBD, helping mobilise the investment needed to deliver a major new home for science and innovation in London."

Raashed Amin, CEO of Emirates NBD UK, said: "One North Quay represents the type of strategic investment that can translate innovation into long-term economic growth. Emirates NBD is proud to support a development of this scale alongside the National Wealth Fund and Barclays, bringing together public and private capital to help deliver the specialist infrastructure needed by the UK's growing life sciences and technology sectors. This financing also reflects our continued commitment to the UK and our ability to deploy capital behind high-quality projects that support the growth of future-focused industries."

Reynolds said: "London's constantly evolving skyline reflects the city's strength as a centre of innovation, and the fact that companies from around the globe want to do business here. The UK is a genuine world-leader in life sciences, and One North Quay, backed by the National Wealth Fund, will bolster that reputation by providing state of the art lab space for businesses to create the medicines and medtech of the future."

Market Context for London Life Sciences Space

Supporting the delivery of specialist infrastructure for life science businesses aligns with the National Wealth Fund's strategy and furthers the government's ambition to make the UK the leading life-sciences economy in Europe by 2030, according to the announcement.

Occupier demand for science and innovation premises has remained active. Take-up across London's Golden Triangle reached 570,000 square feet in the first half of 2026. One North Quay is designed as a high-density, vertically integrated campus rather than a conventional suburban science park, placing specialist uses within Canary Wharf's established transport and amenity environment. It is positioned against London's limited supply of purpose-built wet laboratories and advanced research space, where demand has been met partly through converted or suboptimal premises.

The project also gives Canary Wharf a diversification strategy beyond its traditional financial-services identity. CWG reports more than 90,000 square feet of occupied laboratory and office space elsewhere in its Canary Wharf life-sciences platform, while Kadans Science Partner has been adding occupiers to its London Innovation Centre.

CWG's Land Structure for the Development

CWG granted a 250-year lease over the One North Quay plot to the project joint venture in May 2024. The arrangement generated £23.5 million from the lease consideration and related infrastructure-loan settlement, with an overage payment of up to £65.3 million potentially payable within 30 months of practical completion. The debt financing advances a project already embedded in CWG's long-term development and land strategy, with delivery targeted for the first quarter of 2028.

Sources